Holiday Gift Guide 2019: The Most Extravagant Cannabis Accoutrements – Forbes

As we wind down 2019, the accoutrements used consume cannabis are more luxe than ever. From a diamond encrusted, 24-karat gold ashtray to a Keith Haring-adorned glass collection, here are eight extravagant cannabis gifts to wow the most discerning enthusiast on your list.

Devambez, luxury cannabis, cannabis gifts, cannabis gift guide

Devambez Aesthete

Courtesy Devambez

Devambez Aesthete Set

Devambez’s storied smoking collection represents the long-overlooked art of the rolling paper, raising rituals to the highest level of luxury. Using organic papers hand-crafted from hemp cultivated by a collective of farmers in the Champagne region of France, the Aesthete Set includes two Imperial booklets from the annual limited-edition run, four Vendôme (cones), two matchbooks, and a 24K gold plated tamper—ready-to-gift in an embossed case. $495, 

Sherbinskis, luxury cannabis, cannabis gifts, cannabis gift guide

SHERBINSKIS Presidential Ashtray


SHERBINSKIS Presidential Ashtray

The cult-favorite cannabis company founded by Mr. Sherbinski (aka Mario Guzman), a renowned grower and cultivator of world-famous genetics, is rooted in San Francisco, but has most recently taken on Los Angeles with the opening of its first-ever flagship store. Inside (and online) SHERBINSKIS flower is complemented by signature orange, black, and white branded swag, but its diamond-encrusted, 24-karat gold Presidential Ashtray (the hands permanently sit on 4:20) in collaboration with high fashion label BANA is a serious splurge. $5,000,

Greenlane, Keith Haring, K. Haring Collection, cannabis gifts, luxury cannabis

K. Haring Collection

Courtesy Greenlane

K. Haring Collection

As a personal passion project for Higher Standards founder and Greenlane CMO Sasha Kadey, the just-launched K. Haring Collection features the famed artist’s most iconic works applied to glass. Featuring every essential for an elevated smoking experience, each custom-designed piece features a playful pattern of which Kadey says, “Hopes to carry on Keith Haring’s legacy, break boundaries, and bring colorful works of art into the everyday cannabis lifestyle.” $845 (products sold separately), 

Edie Parker Flower, luxury cannabis, cannabis gifts, cannabis gift guide, Edie Parker

Edie Parker Flower Tabletop Lighter

Courtesy Edie Parker Flower

Edie Parker Tabletop Lighter

Old-school cool meets modern connoisseur in Edie Parker’s entire cannabis line, crafted out of the label’s signature, candy color-coated acrylic. A statement piece for any smoker, the classic tabletop is now available as part of its bespoke collection, which offers your pick of color and initials. Complete a coordinating and covetable coffee table set with a matching monogramed stash jar, vanity tray, rolling tray insert, and stash box. $450,

Mister Green, Maaari, cannabis accessories, luxury cannabis, cannabis gift guide

MAAARI x Mister Green Rolling Caddy and Egg Grinder

Courtesy MAAARI

Maaari x Mister Green

The coming together of MAAARI, a modern design studio inspired by Philippine culture, and Mister Green, “The A.P.C. of Head Shops” was simpatico. With its respective founders each living high-minded lifestyles, the result is a sleek marble grinder in the shape of an egg and a rolling tray with a storage drawer made to live atop a coffee table. $346, 

Double Barrel, luxury cannabis, vaporizer ring, cannabis gifts, cannabis gift guide

Double Barrel Vaporizer

Courtesy Double Barrel

Double Barrel Vaporizer

As the world’s first wearable, dual-oil chamber vaporizing system, Double Barrel is much more than the perfect party trick. Two custom-tuned chambers are filled with pure, potent, and rare cannabis oil blends with a detachable, magnetic knuckle ring. Available in Rose Gold, Buddha Gold, and Gold with DB Reload Kits available in select partner dispensaries in California. $100,

Sackville & Co., luxury cannabis, cannabis gifts, cannabis gift guide

Sackville & Co.

Courtesy Sackville & Co.

Sackville & Co. Holiday Set

Co-founders Hayley Dineen and Lana Van Brunt came to cannabis with combined experience ranging from Vivienne Westwood to VICE to create a design-forward accessories company meant to be flaunted instead of hidden. For the joint lover, give the gift of the greatest grinder ever—a three-tier gilded piece with diamond-sharp teeth. The oversized statement piece comes paired with a six-pack of Sackville & Co’s signature pre-rolled cones made with unbleached rice paper and sealed with arabic gum. $80,

Jacquie Aiche, cannabis gifs, luxury cannabis, sweet leaf, cannabis gift guide

Jacquie Aiche Snakeskin Clutch

Courtesy Jacquie Aiche

Jacquie Aiche Sweet Leaf Clutch

A bauble from jeweler Jacquie Aiche’s cannabis-inspired Sweet Leaf line is always on our wish list, but her bespoke smoker’s clutch is a must-have for this year. The snakeskin zippered wallet is outfitted with slots for an ID and credit card and was made to fit a Lighter Case ($135) and Doob Tube ($440), which are sold separately. Available in black and custom color options if requested via phone or email. $2,400,

Shop my other 2019 Holiday Gift Guides:

Local CBD vendor facing facing federal crackdown suit –

DUBUQUE, Iowa (KWWL) – Since passing earlier this summer, Iowa’s Hemp Act has resulted in a lot of confusion over CBD’s legality.

CBD, also known as cannabidiol, is derived from the hemp plant. And while it is still illegal for most people in Iowa, it’s use has grown in popularity.

Iowa’s Hemp Act opened the doors for legalized hemp production. However, it only applies for products containing less than 0.3% THC; the chemical that gives you a „high.”

According to Iowa Code, it defines all parts of the cannabis plant as marijuana. But, it excludes anything made from mature stalks of the plant or oils made from seeds.

But without a federal approval, you can still be arrested for possession. However, many people can still obtain CBD products online.

Jacob Trone is one of the co-owners of Jacob’s Ladder, which sells CBD products. He operates one store in Dubuque and five other locations in Wisconsin.

Trone’s Dubuque store hadn’t been open for a full month when he was served a lawsuit by the county for selling CBD products.

„It’s been a big growing part in Wisconsin and we wanted to help bring that here in Iowa,” said Trone. „But now it seems like we’re hitting the brakes a little bit.”

Trone could face multiple felony charges if the county decides to pursue legal action. He has since pulled many of his items off of the shelves.

„Hopefully when things adjust and we’re able to sell here, we’ll be here and ready and excited for that,” said Trone.

Trone said that his business will remain open and he wants to educate the public of the benefits of CBD. He is currently seeking counsel and plans to fight the case.

You must be 18 years or older, with a valid ID, to purchase any CBD products.

California considers calling THC in pot a risk to moms-to-be –

LOS ANGELES (AP) — A California panel on Wednesday wrestled with the reliability and accuracy of dense research studies as it considers whether to declare marijuana’s potent, high-inducing chemical — THC — a health risk to pregnant women and require warnings for the pot products legally sold in the nation’s most populous state.

Surveys have indicated that a rising number of mothers-to-be have turned to marijuana products for relief from morning sickness and headaches, though it’s effectiveness has not been backed by science.

The Developmental and Reproductive Toxicant Identification Committee, a group of scientists appointed by the governor, is focusing on whether THC and cannabis smoke cause “reproductive toxicity.”

An affirmative finding would make THC one of hundreds of chemicals judged to cause cancer or birth defects that California requires to carry warning labels, such as arsenic and lead.

The panel met in Sacramento to delve into numerous studies that have examined whether cannabis use during pregnancy can be linked to low birth weight, early deliveries, infant mortality or cognitive or other health problems with children.

They debated whether studies were sufficiently comprehensive and scientifically sound to make judgments about the effects of THC and pregnancy. Some studies didn’t make clear how frequently a mother used cannabis during pregnancy or what products were being used. Others didn’t account for instances when mothers were using marijuana and tobacco and whether that could skew the results.

Because some studies included only tests on animals, such as mice or rats, the panel discussed whether those results could be used to consider the effects on people. In other cases, studies relied on self-reporting by new mothers, putting the reliability of the information in doubt.

It wasn’t clear whether the panel would vote Wednesday.

Cannabis industry officials say too little sound research is available on THC to support such a move and warn that it could make marijuana companies a target for lawsuits with unverified claims of injuries from pot use during pregnancy.

“That seems like an open-ended checkbook. How do we defend ourselves?” said Los Angeles dispensary owner Jerred Kiloh, who heads the United Cannabis Business Association, an industry group.

The review is being carried out under the umbrella of the Safe Drinking Water and Toxic Enforcement Act, better known as Proposition 65. It requires warning labels for chemicals judged as dangerous and allows residents, advocacy groups and attorneys to sue on behalf of the state and collect a portion of civil penalties for failure to provide warnings.

The 1986 law has been credited with weeding out cancer-causing chemicals from products but also faulted for setting the stage for legal shakedowns.

Lawyers looking for a quick buck will say „give us $10,000 or we are going to take you into a long court case,” Kiloh said.

The California Cannabis Industry Association echoed that fear, noting that pot’s standing as an illegal drug at the federal level has choked off research by government agencies. Those studies are needed to determine if THC poses health risks for pregnant women.

“Good policy and consumer protections are based on facts and data,” spokesman Josh Drayton said.

Since 2009, California has listed marijuana smoke as being known to cause cancer, similar to tobacco smoke.

The U.S. surgeon general warned in August that smoking marijuana is dangerous for pregnant women and their developing babies. Mainstream medicine advises against pot use in pregnancy because of studies suggesting it might cause premature birth, low birth weight or other health problems, but many of those studies were in animals or had findings that were open to dispute.

The National Institute on Drug Abuse is paying for several studies on marijuana use during pregnancy.

If the California panel declares pot a risk for pregnant women, it’s not clear what the immediate impact would be on the state’s legal pot industry.

Presumably, packaging would need to be changed over time to carry warning labels for pregnant women. But such requirements would likely take additional steps by agencies that oversee marijuana regulation and packaging.

Even products containing CBD, a trendy ingredient extracted from marijuana or hemp, can contain trace amounts of THC.


Blood reported from Los Angeles. He is a member of AP’s marijuana beat team. Follow him on Twitter at Follow AP’s complete marijuana coverage:

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Michael R. Blood

2019’s Top Eight Cannabis Podcasts You Need In Your Life – Forbes

Lauren Hurt

Weed+Grub. Photo credit Lauren Hurt.

Photo: Lauren Hurt

2019’s Top 8 Cannabis Podcasts You Need in Your Life

I wish that I had more time in the day to listen to podcasts because there are so many out there that have such a powerful influence! How many hours are there in a day? Not enough. I’m still working through Brian Eno Music For Films as my go-to for work-time listening. Fat chance for me to find time to listen to anything new during my usual work day, but when I travel, which is much these days, I find myself listening to podcasts. Among the best are this list of eight cannabis podcasts you need in your life. When I can turn off the phone for six or so hours, I’ll dive into a few good podcasts. Well friends, I hope you start here with this brilliant list of talented weed people.

Let's Talk Hemp

Screen Shot 2019-12-04 at 3.35.56 PM

courtesy: Let’s Talk Hemp

Let’s Talk Hemp & the 422 Podcasts

“#EverydayIsEarthDay @ #The422— The #422 is a weekly podcast hosted by Morris Beegle and Rick Trojan that talks about all things hemp and cannabis. It reiterates that hemp is cannabis… it’s all cannabis, and this plant should be embraced by all walks of life.  The benefits are vast and the non-benefits are nil.”

Listen:  (Click)


weed and grub


Courtesy: Weed+Grub


“Spark up and chow down with Mike Glazer and Mary Jane (yes, that’s her real name) as they smoke, snack, and swap tales about cannabis, comedy, sex, cooking, pop culture… basically everything you already love. Weed + Grub is two friends sharing laughs and stories from their insane lives, and interviewing fascinating guests from all walks of life. Light a joint, grab a bite and come along.”

Listen: (Click)



Screen Shot 2019-12-04 at 3.31.36 PM

Photo Courtesy: Chronic Relief

Chronic Relief 

“Chronic Relief is a podcast where comedians have an honest conversation about comedy, cannabis, and mental health, hosted by comedian Rachel Wolfson. Each guest talks about their experiences with mental health and how they have coped with it in their own way.”

Listen: (Click)


Broccoli Talk

Screen Shot 2019-12-04 at 3.36.35 PM

Photo Courtesy: Broccoli Talk

Broccoli Talk: A Podcast for Cannabis Lovers

Tune in every two weeks to Broccoli Talk for casual chats with your weed BFFs. Co-hosted by Lauren Yoshiko and Mennlay Golokeh Aggrey, we’ll be exploring the world of cannabis through interviews, discussions, readings and more. 




Screen Shot 2019-12-04 at 3.22.18 PM

Photo Courtesy: BBM

Blunt Blowin’ Mama

“A podcast for all the moms and women who proudly consume cannabis and proclaim: „I’m not a regular mom, I’m a stoner mom.””



Weed Week Podcast


Screen Shot 2019-12-04 at 3.32.03 PM

Photo Courtesy: Weedweek

“Every Monday, Donnell Alexander and Alex Halperin break down the latest news and bring you conversations with the people shaping the future of cannabis.”



Periodic Effects


Screen Shot 2019-12-04 at 3.37.48 PM

Photo Courtesy: Periodic effects

“The Periodic Effects podcast focuses on the Business & Science of Cannabis. Bringing you an insider look at cannabis business operators and the latest studies on cannabis science research. If you’re operating in the cannabis industry, a budtender looking to learn more, or a consumer wondering how cannabis can help you, this is the podcast for you!”



Let's be blunt

Screen Shot 2019-12-04 at 3.28.01 PM

Photo Courtesy: Let’s be Blunt

Let’s Be Blunt Podcast w/ Montel Williams

A cannabis lifestyle and interview show, „Let’s Be Blunt” explores the intersection of cannabis, activism, health, and wellness. Hosted by Montel Williams, the podcast works to bridge the gap between common cannabis knowledge and in-depth research, while also giving high-profile guests a chance to “be blunt” about their lives, what they’re passionate about, and what they believe in New Episodes every Thursday and Sunday.



Marijuana Legalization Bill Filed In Virginia Ahead Of Attorney General’s Cannabis Summit – Marijuana Moment

The attorney general of Virginia held a cannabis summit on Wednesday, with representatives of states that have legalized marijuana sharing their insights as lawmakers in the Commonwealth prepare to push reform legislation in the coming session.

This event came one day after a lawmaker prefiled a bill to legalize marijuana for adult use and expand the state’s existing limited medical cannabis program.

The event featured panels on marijuana decriminalization, social equity, public health, hemp, CBD and creating a pathway for eventual legalization. The goal was to answer policy questions and inform legislation, which Attorney General Mark Herring (D) hopes will start with decriminalization and expungements and later adult-use legalization.

“I don’t believe that Virginia’s current approach of criminalizing cannabis is working,” Herring said in his opening remarks. “It is needlessly creating criminals and burdening Virginians with convictions.”

“The human and social costs are enormous, in addition to the millions of dollars it costs Virginia taxpayers. And the negative consequences of the current approach fall disproportionately on African Americans and people of color,” he said. “It’s clear to me that the time for cannabis reform has come. Justice demands it. Virginians are demanding it. And I’m going to help make sure we get this right.”

Watch video of the Virginia Cannabis Summit  below: 

In one year, Canadians spent $908M on legal cannabis – Global News

OTTAWA — Canadians spent about $908 million on non-medical cannabis in the first year since legalization, but online sales dropped as more brick-and-mortar locations opened, said Statistics Canada .

Canadians spent $907,833,000 on non-medical cannabis between October 2018 and September 2019, the agency said, which works out to $24 per capita.

READ MORE: Cannabis and driving study casts doubt on zero-tolerance limits for THC

Canada legalized cannabis on Oct. 17, 2018, becoming the second country in the world — after Uruguay — to legalize the drug. Demand initially appeared to outstrip supply as retailers warned of a pending shortfall of product.

Over the year, demand appeared to be highest in the sparsely populated Yukon where sales per capita led the other provinces and territories at $103, according to Statistics Canada. It was not able to provide data for Nunavut _ the only area without a physical store.

Story continues below advertisement

Prince Edward Island sales per capita were the second highest at $97, while B.C. ranked lowest at $10.

THC lingers long after its effects are gone

THC lingers long after its effects are gone

Throughout the year, Canadians’ access to cannabis stores increased. The number of retail stores jumped from 217 this past March to 407 in July, according to the agency.

Alberta boasts the highest number of stores at 176 and B.C. took second place with 57 stores. Nunavut had the fewest with zero, followed by Prince Edward Island and the Yukon, both of which have four.

READ MORE: Cannabis vaping products won’t be sold in Quebec, N.L. in January

Nineteen per cent of Canadians lived three kilometres from a cannabis store as of July 2019. Thirty per cent lived 30 kilometres away and 45 per cent lived within 10 kilometres.

Albertans enjoyed the closest proximity to a store of any province, with half of the population living within three kilometres of a cannabis outlet. That figure rises to 63 per cent for five kilometres and 70 per cent for 10 kilometres.

Ontarians lived the furthest from cannabis stores on average. Nine per cent of the population resided three kilometres from a cannabis store. Eighteen per cent lived five kilometres away and 33 per cent were 10 kilometres away.

Story continues below advertisement

As the number of physical stores increased, the share of online sales dropped from 43.4 per cent in October 2018 to 5.9 per cent in September 2019.

READ MORE: Constellation executive David Klein named new CEO of Canopy Growth

“While online cannabis retail ensures access to all Canadians regardless of proximity to a physical store, accessibility continues to improve as more stores open across the country,” wrote Statistics Canada in its paper.

As of July, Canada had 407 cannabis retail stores, with the most being located in Alberta.

About 45 per cent of Canadians live within 10 kilometres of a cannabis store as of July, but that figure shoots up to encompass 70 per cent of the population in Alberta.

© 2019 The Canadian Press

THC and California Proposition 65: What’s in Store for CBD Product Labeling? – JD Supra

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC („JD Supra” or „we,” „us,” or „our„) collects, uses and shares personal data collected from visitors to our website (located at (our „Website„) who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our „Services„). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the „My Account” dashboard (available if you are logged into your JD Supra account).

Collection of Information

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account („Registration Data„), such as your:

  • Email
  • First Name
  • Last Name
  • Company Name
  • Company Industry
  • Title
  • Country

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users’ movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our „Cookies Guide” page.

How do we use this information?

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

  • Operate our Website and Services and publish content;
  • Distribute content to you in accordance with your preferences as well as to provide other notifications to you (for example, updates about our policies and terms);
  • Measure readership and usage of the Website and Services;
  • Communicate with you regarding your questions and requests;
  • Authenticate users and to provide for the safety and security of our Website and Services;
  • Conduct research and similar activities to improve our Website and Services; and
  • Comply with our legal and regulatory responsibilities and to enforce our rights.

How is your information shared?

  • Content and other public information (such as an author profile) is shared on our Website and Services, including via email digests and social media feeds, and is accessible to the general public.
  • If you choose to use our Website and Services to communicate directly with a company or individual, such communication may be shared accordingly.
  • Readership information is provided to publishing law firms and authors of content to give them insight into their readership and to help them to improve their content.
  • Our Website may offer you the opportunity to share information through our Website, such as through Facebook’s „Like” or Twitter’s „Tweet” button. We offer this functionality to help generate interest in our Website and content and to permit you to recommend content to your contacts. You should be aware that sharing through such functionality may result in information being collected by the applicable social media network and possibly being made publicly available (for example, through a search engine). Any such information collection would be subject to such third party social media network’s privacy policy.
  • Your information may also be shared to parties who support our business, such as professional advisors as well as web-hosting providers, analytics providers and other information technology providers.
  • Any court, governmental authority, law enforcement agency or other third party where we believe disclosure is necessary to comply with a legal or regulatory obligation, or otherwise to protect our rights, the rights of any third party or individuals’ personal safety, or to detect, prevent, or otherwise address fraud, security or safety issues.
  • To our affiliated entities and in connection with the sale, assignment or other transfer of our company or our business.

How We Protect Your Information

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at

Children’s Information

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Links to Other Websites

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

Information for EU and Swiss Residents

JD Supra’s principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

  • Our Legal Basis for Processing: Generally, we rely on our legitimate interests in order to process your personal information. For example, we rely on this legal ground if we use your personal information to manage your Registration Data and administer our relationship with you; to deliver our Website and Services; understand and improve our Website and Services; report reader analytics to our authors; to personalize your experience on our Website and Services; and where necessary to protect or defend our or another’s rights or property, or to detect, prevent, or otherwise address fraud, security, safety or privacy issues. Please see Article 6(1)(f) of the E.U. General Data Protection Regulation („GDPR”) In addition, there may be other situations where other grounds for processing may exist, such as where processing is a result of legal requirements (GDPR Article 6(1)(c)) or for reasons of public interest (GDPR Article 6(1)(e)). Please see the „Your Rights” section of this Privacy Policy immediately below for more information about how you may request that we limit or refrain from processing your personal information.
  • Your Rights
    • Right of Access/Portability: You can ask to review details about the information we hold about you and how that information has been used and disclosed. Note that we may request to verify your identification before fulfilling your request. You can also request that your personal information is provided to you in a commonly used electronic format so that you can share it with other organizations.
    • Right to Correct Information: You may ask that we make corrections to any information we hold, if you believe such correction to be necessary.
    • Right to Restrict Our Processing or Erasure of Information: You also have the right in certain circumstances to ask us to restrict processing of your personal information or to erase your personal information. Where you have consented to our use of your personal information, you can withdraw your consent at any time.

You can make a request to exercise any of these rights by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

You can also manage your profile and subscriptions through our Privacy Center under the „My Account” dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use „automatic decision making” or „profiling” as those terms are defined in the GDPR.

  • Timeframe for retaining your personal information: We will retain your personal information in a form that identifies you only for as long as it serves the purpose(s) for which it was initially collected as stated in this Privacy Policy, or subsequently authorized. We may continue processing your personal information for longer periods, but only for the time and to the extent such processing reasonably serves the purposes of archiving in the public interest, journalism, literature and art, scientific or historical research and statistical analysis, and subject to the protection of this Privacy Policy. For example, if you are an author, your personal information may continue to be published in connection with your article indefinitely. When we have no ongoing legitimate business need to process your personal information, we will either delete or anonymize it, or, if this is not possible (for example, because your personal information has been stored in backup archives), then we will securely store your personal information and isolate it from any further processing until deletion is possible.
  • Onward Transfer to Third Parties: As noted in the „How We Share Your Data” Section above, JD Supra may share your information with third parties. When JD Supra discloses your personal information to third parties, we have ensured that such third parties have either certified under the EU-U.S. or Swiss Privacy Shield Framework and will process all personal data received from EU member states/Switzerland in reliance on the applicable Privacy Shield Framework or that they have been subjected to strict contractual provisions in their contract with us to guarantee an adequate level of data protection for your data.

California Privacy Rights

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at or by writing to us at:

Privacy Officer
JD Supra, LLC
10 Liberty Ship Way, Suite 300
Sausalito, California 94965

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

Access/Correct/Update/Delete Personal Information

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the „My Account” dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to

Changes in Our Privacy Policy

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

Contacting JD Supra

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at:

As with many websites, JD Supra’s website (located at (our „Website„) and our services (such as our email article digests)(our „Services„) use a standard technology called a „cookie” and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

How We Use Cookies and Other Tracking Technologies

We use cookies and other tracking technologies to:

  1. Improve the user experience on our Website and Services;
  2. Store the authorization token that users receive when they login to the private areas of our Website. This token is specific to a user’s login session and requires a valid username and password to obtain. It is required to access the user’s profile information, subscriptions, and analytics;
  3. Track anonymous site usage; and
  4. Permit connectivity with social media networks to permit content sharing.

There are different types of cookies and other technologies used our Website, notably:

  • Session cookies” – These cookies only last as long as your online session, and disappear from your computer or device when you close your browser (like Internet Explorer, Google Chrome or Safari).
  • Persistent cookies” – These cookies stay on your computer or device after your browser has been closed and last for a time specified in the cookie. We use persistent cookies when we need to know who you are for more than one browsing session. For example, we use them to remember your preferences for the next time you visit.
  • Web Beacons/Pixels” – Some of our web pages and emails may also contain small electronic images known as web beacons, clear GIFs or single-pixel GIFs. These images are placed on a web page or email and typically work in conjunction with cookies to collect data. We use these images to identify our users and user behavior, such as counting the number of users who have visited a web page or acted upon one of our email digests.

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

  • HubSpot – For more information about HubSpot cookies, please visit
  • New Relic – For more information on New Relic cookies, please visit
  • Google Analytics – For more information on Google Analytics cookies, visit To opt-out of being tracked by Google Analytics across all websites visit This will allow you to download and install a Google Analytics cookie-free web browser.

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the „Like,” „Tweet,” or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

Controlling and Deleting Cookies

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It’s also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser’s „Help” function or alternatively, you can visit which explains, step-by-step, how to control and delete cookies in most browsers.

Updates to This Policy

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

Contacting JD Supra

If you have any questions about how we use cookies and other tracking technologies, please contact us at:

Is CBD the New E-Cig Scare? – The Motley Fool

The Food and Drug Administration still refuses to acknowledge electronic cigarettes may be a healthier alternative to traditional cigarettes, even though much of the rest of the world actively promotes smokers switching to e-cigs as safer.

The agency used an outbreak of lung injuries and deaths this summer related to vaping to urge the public to stop using the devices altogether until it knows more about what caused the illnesses, even though it all but confirmed they were related to illicit e-liquids bought over the internet.

Scientist putting drops of oil in a bottle next to marijuana plants.

Image source: Getty Images.

Now the agency is using a similar tactic with cannabidiol, or CBD, the nonpsychotropic compound found in marijuana and hemp, reiterating that not only is it illegal to use CBD in food or to market it as a supplement, but that there are also just too many unknowns for people to safely use CBD.

The results of both of these actions were predictable: The companies invested in these products were crushed in the market. 

The future is still cloudy for CBD

The FDA admits there is „significant public interest” in cannabis and cannabis compounds like CBD, but it warns consumers not to be lulled into thinking they’re safe. The agency did approve GW Pharmaceutical‚s (NASDAQ:GWPH) Epilodex drug containing CBD to treat two rare illnesses. But even the pharmaceutical-grade compound in Epilodex exposed users to potential side effects including liver damage, reactions to other drugs, and harm to male reproductive function.

The potential ramifications of using over-the-counter formulations of CBD remain murky, especially if people are using it simultaneously across multiple applications, such as in edibles and in topical creams. The impact on certain populations like the elderly, children, or even lactating mothers is unknown.

It’s not exactly fear-mongering, especially since the FDA says it wants to use a science-based approach to approve products to market and the agency needs to be cautious when it comes to public health. It says it wants consumers to have the facts before using CBD products.

Yet the regulatory body hasn’t moved quickly in formulating a clear policy on CBD, all the while citing the risks associated with it, which results in the scales tipping toward opposition. And it could be years before official policy becomes more balanced.

Erecting hurdles to adoption

That’s not unlike the situation with e-cigs, which are generally recognized as a safer and healthier option for smokers. The FDA has yet to label any device as reduced-risk (but it did approve Swedish Match‚s brand of snus, which is a moist, powdered tobacco product).

Although the agency’s advisory panel recommended that the heat-not-burn e-cig from Philip Morris International (NYSE:PM) be approved for a reduced-risk label, the FDA has not acted on it for three years now, even though the application was submitted months before the marketing application.

Instead, the FDA has spent a lot of time taking the industry to task for a reported rise in teenage use of e-cigs and has targeted leading manufacturer Juul Labs for particular scrutiny. Altria (NYSE:MO) was forced to write down more than a quarter of the value of its $12.8 billion investment in the e-cig maker, which it was also excoriated for by investors. The agency has also proposed banning all flavored e-liquids, even though adults use flavors to help them transition away from smoking.

Never let a crisis go to waste

Rather than encourage smokers to make the switch to e-cigs, the FDA has made it clear that it views any nicotine use as harmful and has erected an expensive, labyrinthine approval process (so far, only two of the biggest tobacco giants have managed to submit applications for review). The deadline for the industry is May 2020, suggesting many won’t make it.

It also used the outbreak of lung illnesses to bolster its animus against the industry, even though not a single e-cig manufacturer has been implicated in the health scare. 

As a result, the growth in e-cig use has tumbled while the decline in cigarette smoking has eased, suggesting people have stopped using e-cigs and taken up smoking again. That can hardly be considered a policy win.

CBD and e-cigs remain in limbo

The recent policy clarification on CBD doesn’t seem much different. The FDA used the opportunity to highlight the risks and discuss how it’s cracking down on companies violating its rules, but didn’t offer any illumination on when a cohesive framework for regulation would be forthcoming. Since we already knew the FDA would lean against CBD use, much as it is against e-cigs, it makes it difficult for any pot producers wanting to offer CBD-infused products.

Investors in both CBD and e-cigs may want to proceed cautiously as the regulatory landscape remains uncertain because of the FDA.

Tenet Healthcare (THC) Is Up 10.34% in One Week: What You Should Know – Yahoo Finance

Warning: sprintf(): Too few arguments in /var/www/ on line 319

Momentum investing revolves around the idea of following a stock’s recent trend in either direction. In the ‚long’ context, investors will be essentially be „buying high, but hoping to sell even higher.” With this methodology, taking advantage of trends in a stock’s price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.

Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.

It’s also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Tenet Healthcare currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.

You can see the current list of Zacks #1 Rank Stocks here >>>

Let’s discuss some of the components of the Momentum Style Score for THC that show why this hospital operator shows promise as a solid momentum pick.

A good momentum benchmark for a stock is to look at its short-term price activity, as this can reflect both current interest and if buyers or sellers currently have the upper hand. It is also useful to compare a security to its industry, as this can help investors pinpoint the top companies in a particular area.

For THC, shares are up 10.34% over the past week while the Zacks Medical – Hospital industry is up 2.52% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 23.91% compares favorably with the industry’s 3.61% performance as well.

While any stock can see its price increase, it takes a real winner to consistently beat the market. That is why looking at longer term price metrics — such as performance over the past three months or year — can be useful as well. Over the past quarter, shares of Tenet Healthcare have risen 48.32%, and are up 58.81% in the last year. On the other hand, the S&P 500 has only moved 5.64% and 21%, respectively.

Investors should also pay attention to THC’s average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. THC is currently averaging 1,017,886 shares for the last 20 days.

The Zacks Momentum Style Score encompasses many things, including estimate revisions and a stock’s price movement. Investors should note that earnings estimates are also significant to the Zacks Rank, and a nice path here can be promising. We have recently been noticing this with THC.

Over the past two months, 8 earnings estimates moved higher compared to 1 lower for the full year. These revisions helped boost THC’s consensus estimate, increasing from $2.40 to $2.70 in the past 60 days. Looking at the next fiscal year, 6 estimates have moved upwards while there have been 3 downward revisions in the same time period.

Taking into account all of these elements, it should come as no surprise that THC is a #2 (Buy) stock with a Momentum Score of A. If you’ve been searching for a fresh pick that’s set to rise in the near-term, make sure to keep Tenet Healthcare on your short list.

Click to get this free report
Tenet Healthcare Corporation (THC) : Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research” data-reactid=”34″>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Tenet Healthcare Corporation (THC) : Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research